1. Home
  2. ATXG vs HCWB Comparison

ATXG vs HCWB Comparison

Compare ATXG & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

HOLD

Current Price

$0.46

Market Cap

5.5M

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.53

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATXG
HCWB
Founded
2014
2018
Country
China
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATXG
HCWB
Price
$0.46
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
54.1K
49.4K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,141,952.00
$422,026.00
Revenue This Year
N/A
$178.64
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.52
52 Week High
$1.86
$41.20

Technical Indicators

Market Signals
Indicator
ATXG
HCWB
Relative Strength Index (RSI) 42.73 27.48
Support Level $0.46 $1.52
Resistance Level $0.50 $2.15
Average True Range (ATR) 0.03 0.16
MACD 0.00 0.02
Stochastic Oscillator 21.77 2.22

Price Performance

Historical Comparison
ATXG
HCWB

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: